Showing results (191-200 of 239) with videos related to
Sort By:
Pageof 24
New Zealand Veterinary Journal|November 2, 2011
Dynamics of the free-living stages of sheep intestinal parasites on pasture in the North Island of New Zealand. 1. Patterns of seasonal developmentT S Waghorn, D P Reynecke, A-M B Oliver, et al.Clinical Transplants|January 1, 1994
Liver transplantation at Mount Sinai HospitalE Mor, P A Sheiner, M E Schwartz, et al.Transplantation|July 27, 1997
Use of livers with microvesicular fat safely expands the donor poolT M Fishbein, M I Fiel, S Emre, et al.Clinical Transplants|August 22, 2001
Liver transplantation at Mount SinaiL Kim-Schluger, S S Florman, G Gondolesi, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipientsS Emre, Y Genyk, L K Schluger, et al.Journal of Applied Microbiology|August 26, 1998
Ecomycins, unique antimycotics from Pseudomonas viridiflavaC M Miller, R V Miller, D Garton-Kenny, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1995
CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantationA Fisher, N D Theise, A Min, et al.Journal of the American College of Surgeons|May 1, 1995
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosisM E Schwartz, M Sung, E Mor, et al.Hepatology (Baltimore, Md.)|September 26, 2000
Liver transplantation for autoimmune hepatitisD J Reich, I Fiel, J V Guarrera, et al.Journal of the American College of Surgeons|April 1, 1996
Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipientsA R Manasia, A B Leibowitz, C M Miller, et al.Pageof 24